|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||82.13 - 83.39|
|52 Week Range||63.76 - 86.27|
|PE Ratio (TTM)||8.94|
|Dividend & Yield||2.08 (2.53%)|
|1y Target Est||N/A|
Gilead Sciences (GILD) appears to be a good choice for value investors right now, given its favorable metrics and estimate revisions.
The "Fast Money" traders share their first moves as the market opens.
The iShares NASDAQ Biotechnology ETF (IBB) offers investors targeted exposure to biotechnology and pharmaceutical stocks listed on the NASDAQ.